The weekly litigation news digest is live. Subscribe now

IP Verse

Combination Of Direct Acting Antiviral Agents And Ribavirin For Treating Hcv Patients - EP2968302

The patent EP2968302 was granted to Abbvie on Feb 13, 2019. The application was filed on Mar 14, 2014 under application number EP14725812A. The patent is currently recorded with a legal status of "Revoked".

EP2968302

ABBVIE
Application Number
EP14725812A
Filing Date
Mar 14, 2014
Status
Revoked
Sep 2, 2020
Publication Date
Feb 13, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GENERICS UKJun 6, 2018TER MEER STEINMEISTER & PARTNER -

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2012070416
DESCRIPTIONUS2012220562
DESCRIPTIONUS2013102526
INTERNATIONAL-SEARCH-REPORTUS2012004196
INTERNATIONAL-SEARCH-REPORTUS2012070416
OPPOSITIONEP2583677
OPPOSITIONUS2012070416
OPPOSITIONUS2012220562
OPPOSITIONUS2013102526
OPPOSITIONWO2014152635

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents